Pages

Monday, November 25, 2019

The impact of LEAVO study in Greece

Currently in Greece, intravitreal bevacizumab cannot be officially used and only the two licensed anti-VEGF agents can be provided to patients with retinal diseases in both the private and public ...


READ THE ORIGINAL POST AT www.nature.com